The research project, named IMPACT – Cardiogenomics meets Artificial Intelligence: a step forward in arrhythmogenic cardiomyopathy diagnosis and treatment – will run for 36 months and has been funded with […]
Autor: Firma Ksilink
environMENTAL – New EU-Funded project reveals the role of environMENTAL factors for mental illnesses
The EU-funded project environMENTAL is holding its kick-off meeting to initiate its investigation on the influence of global environmental challenges on brain and mental health. The international consortium led by Prof. […]
Myrtil Biotechnologies – innovative Arzneimittelforschung für Patienten mit dilatativer Kardiomyopathie
Im Rahmen einer langfristigen Zusammenarbeit haben Ksilink und myriamed gemeinsam ein aus induzierten pluripotenten Stammzellen (iPSC) abgeleitetes Modell der dilatativen Kardiomyopathie (DCM) entwickelt und validiert, das nun von dem neu […]
Myrtil Biotechnologies – innovating drug discovery for patients with dilated cardiomyopathy
In a long-term collaboration, Ksilink and myriamed jointly established and validated an induced pluripotent stem cell (iPSC)-derived model of dilated cardiomyopathy (DCM), which will now be exploited by the newly […]
Ksilink, joining academic-industry cell imaging consortium
The Joint Undertaking in Morphological Profiling with Cell Painting aims to accelerate drug discovery and development by creating a massive dataset of cells imaged under more than 140,000 different conditions. […]
Ksilink tritt renommiertem Konsortium für Zellbildgebung bei
Das Konsortium “Joint Undertaking in Morphological Profiling with Cell Painting” (JUMP-CP) zielt darauf ab, die Entdeckung und Entwicklung von Arzneimitteln zu beschleunigen, indem ein großer Datensatz von Zellen erstellt wird, […]